Lamotrigin Actavis (Lamotrigine)

Lamotrigine works by blocking voltage‑gated sodium channels on neurons, which stabilises the neuronal membrane and reduces the release of excitatory neurotransmitters such as glutamate. This action lowers neuronal hyper‑excitability, helping to control seizures and stabilize mood.

The dosage of Lamotrigin Actavis is individualized by the prescribing clinician based on the patient’s age, condition, renal and hepatic function, and other concurrent medications. The prescriber determines the appropriate starting dose and titration schedule.

The safety of lamotrigine in pregnancy and lactation is not fully established. Healthcare providers weigh potential benefits against possible risks, and women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their physician.

To request Lamotrigin Actavis, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lamotrigin Actavis differs from many anticonvulsants by primarily targeting sodium channels and having a relatively favorable cognitive side‑effect profile. Compared with older agents such as carbamazepine, it has fewer drug‑induced enzyme interactions but requires careful monitoring when combined with valproic acid or oral contraceptives.

Lamotrigin Actavis should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Lamotrigin Actavis is taken orally, usually as a tablet, with or without food as directed by the prescriber. The tablets are swallowed whole with a glass of water; they should not be crushed, chewed, or split unless specifically advised.

Serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood dyscrasias like agranulocytosis, and the emergence or worsening of suicidal thoughts. Prompt medical attention is required if any of these events occur.

Patients with known hypersensitivity to lamotrigine or any component of the formulation should avoid the product. Caution is also advised for individuals with a history of severe skin reactions, significant hepatic impairment, or those taking interacting medications without appropriate dose adjustments.